Optimization, and in vitro and in vivo evaluation of etomidate intravenous lipid emulsion

References

• Agrawal U, Chashoo G, Sharma PR, et al. (2015). Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting. Colloids Surf B Biointerfaces 126:414–25.
   PubMed Web of Science ®Google Scholar
• Ahmed HH, Galal AF, Shalby AB, et al. (2018). Improving anti-cancer potentiality and bioavailability of gallic acid by designing polymeric nanocomposite formulation. Asian Pac J Cancer Prev 19:3137–46.
   PubMedGoogle Scholar
• Anez-Bustillos L, Dao DT, Baker MA, et al. (2016). Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences. Nutr Clin Pract 31:596–609.
   PubMed Web of Science ®Google Scholar
• Bernardi DS, Pereira TA, Maciel NR, et al. (2011). Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments. J Nanobiotechnol 9:44.
   PubMed Web of Science ®Google Scholar
• Carpentier YA, Simoens C, Siderova V, et al. (1997). Recent developments in lipid emulsions: relevance to intensive care. Nutrition 13:73s–8s.
   PubMed Web of Science ®Google Scholar
• Doenicke A, Roizen MF, Hoernecke R, et al. (1997). Haemolysis after etomidate: comparison of propylene glycol and lipid formulations. Br J Anaesth 79:386–8.
   PubMed Web of Science ®Google Scholar
• Doenicke AW, Roizen MF, Hoernecke R, et al. (1999). Solvent for etomidate may cause pain and adverse effects. Br J Anaesth 83:464–6.
   PubMed Web of Science ®Google Scholar
• Dong W, Zhang L, Niu Y, et al. (2013). A stable and practical etoposide-containing intravenous long-/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacy. Expert Opin Drug Deliv 10:559–71.
   PubMed Web of Science ®Google Scholar
• Elmowafy M, Alruwaili NK, Shalaby K, et al. (2020). Long-acting paliperidone parenteral formulations based on polycaprolactone nanoparticles; the influence of stabilizer and chitosan on in vitro release, protein adsorption, and cytotoxicity. Pharmaceutics 12:160.
   PubMed Web of Science ®Google Scholar
• Erdoes G, Basciani RM, Eberle B. (2014). Etomidate–a review of robust evidence for its use in various clinical scenarios. Acta Anaesthesiol Scand 58:380–9.
   PubMed Web of Science ®Google Scholar
• Forman SA, Warner DS. (2011). Clinical and molecular pharmacology of etomidate. Anesthesiology 114:695–707.
   PubMed Web of Science ®Google Scholar
• Ganzberg S. (2017). The FDA warning on anesthesia drugs. Anesth Prog 64:57–8.
   PubMedGoogle Scholar
• Gill RS, Scott RP. (1992). Etomidate shortens the onset time of neuromuscular block. Br J Anaesth 69:444–6.
   PubMed Web of Science ®Google Scholar
• Gou J, Chao Y, Liang Y, et al. (2016). Humid heat autoclaving of hybrid nanoparticles achieved by decreased nanoparticle concentration and improved nanoparticle stability using medium chain triglycerides as a modifier. Pharm Res 33:2140–51.
   PubMed Web of Science ®Google Scholar
• Gou J, Feng S, Liang Y, et al. (2017). Polyester-solid lipid mixed nanoparticles with improved stability in gastro-intestinal tract facilitated oral delivery of larotaxel. Mol. Pharmaceutics14:3750–61.
   PubMed Web of Science ®Google Scholar
• Janssen PA, Niemegeers CJ, Marsboom RP. (1975). Etomidate, a potent non-barbiturate hypnotic. Intravenous etomidate in mice, rats, guinea-pigs, rabbits and dogs. Arch Int Pharmacodyn Ther 214:92–132.
   PubMedGoogle Scholar
• Latson TW, McCarroll SM, Mirhej MA, et al. (1992). Effects of three anesthetic induction techniques on heart rate variability. J Clin Anesth 4:265–76.
   PubMed Web of Science ®Google Scholar
• Li Y, Jin W, Yan H, et al. (2013). Development of intravenous lipid emulsion of vinorelbine based on drug-phospholipid complex technique. Int J Pharm 454:472–7.
   PubMed Web of Science ®Google Scholar
• Lin Y, Pan Y, Shi Y, et al. (2012). Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain. Nanotechnology 23:165101.
   PubMed Web of Science ®Google Scholar
• Luo L, Chen Q, Wei N, et al. (2019). The modulation of drug-loading stability within lipid membranes via medium chain triglycerides incorporation. Int J Pharm 566:371–82.
   PubMedGoogle Scholar
• Meuldermans WE, Heykants JJ (1976). The plasma protein binding and distribution of etomidate in dog, rat and human blood. Arch Int Pharmacodyn Ther 221:150–62.
   PubMedGoogle Scholar
• Moghimi SM, Szebeni J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–78.
   PubMed Web of Science ®Google Scholar
• Moss E, Powell D, Gibson RM, et al. (1979). Effect of etomidate on intracranial pressure and cerebral perfusion pressure. Br J Anaesth 51:347–52.
   PubMed Web of Science ®Google Scholar
• Powell KC, Damitz R, Chauhan A. (2017). Relating emulsion stability to interfacial properties for pharmaceutical emulsions stabilized by Pluronic F68 surfactant. Int J Pharm 521:8–18.
   PubMedGoogle Scholar
• Raman M, Almutairdi A, Mulesa L, et al. (2017). Parenteral nutrition and lipids. Nutrients 9:388.
   PubMed Web of Science ®Google Scholar
• Salmela L and Washington C. (2014). A continuous flow method for estimation of drug release rates from emulsion formulations. Int J Pharm 472:276–81.
   PubMedGoogle Scholar
• Shi S, Chen H, Lin X, et al. (2010). Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion. Int J Pharm 383:264–70.
   PubMed Web of Science ®Google Scholar
• Ton MN, Chang C, Carpentier YA, et al. (2005). In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. Clin Nutr 24:492–501.
   PubMed Web of Science ®Google Scholar
• Vanlersberghe C, Camu F. (2008). Etomidate and other non-barbiturates. Handb Exp Pharmacol 182:267–82.
   Google Scholar
• Wang B, Tian H and Xiang D. (2020). Stabilizing the oil-in-water emulsions using the mixtures of dendrobium officinale polysaccharides and gum arabic or propylene glycol alginate. Molecules, 25:759.
   PubMed Web of Science ®Google Scholar
• Weng D, Huang M, Jiang R, et al. (2013). Clinical study of etomidate emulsion combined with remifentanil in general anesthesia. Drug Des Devel Ther 7:771–6.
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Y, Que L. (2006). Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm 63:288–94.
   PubMed Web of Science ®Google Scholar
• Xiao K, Li Y, Luo J, et al. (2011). The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 32:3435–46.
   PubMed Web of Science ®Google Scholar
• Zhang K, Lv S, Li X, et al. (2013). Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin. Int J Nanomedicine 8:3227–39.
   PubMed Web of Science ®Google Scholar